OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
Shiqi Kong, Yingxiao Cao, Xin Li, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 8, pp. 4677-4686
Open Access | Times Cited: 19
Shiqi Kong, Yingxiao Cao, Xin Li, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 8, pp. 4677-4686
Open Access | Times Cited: 19
Showing 19 citing articles:
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
Jakub Szymczyk, Katarzyna Dominika Sluzalska, Izabela Materla, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5796-5796
Open Access | Times Cited: 61
Jakub Szymczyk, Katarzyna Dominika Sluzalska, Izabela Materla, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5796-5796
Open Access | Times Cited: 61
FGFR families: biological functions and therapeutic interventions in tumors
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 36
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 36
The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
Subhasmita Mahapatra, Nisha Amarnath Jonniya, Suman Koirala, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13509-13533
Closed Access | Times Cited: 17
Subhasmita Mahapatra, Nisha Amarnath Jonniya, Suman Koirala, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13509-13533
Closed Access | Times Cited: 17
MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance
Yugendran Jegathesan, Pashaun Paveen Stephen, Isra Saif Eldin Eisa Sati, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116277-116277
Open Access | Times Cited: 7
Yugendran Jegathesan, Pashaun Paveen Stephen, Isra Saif Eldin Eisa Sati, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116277-116277
Open Access | Times Cited: 7
Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs
Aryan Rezaee, Pooya M. Tehrany, Farimah Jafari Tirabadi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115187-115187
Open Access | Times Cited: 10
Aryan Rezaee, Pooya M. Tehrany, Farimah Jafari Tirabadi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115187-115187
Open Access | Times Cited: 10
CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1
Ruirui Zhang, Huanyu Zhao, Hongmei Yuan, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
Ruirui Zhang, Huanyu Zhao, Hongmei Yuan, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform
Shokoofeh Ghaemi, Zahra Fekrirad, Nina Zamani, et al.
Journal of drug targeting (2022) Vol. 30, Iss. 6, pp. 589-602
Closed Access | Times Cited: 11
Shokoofeh Ghaemi, Zahra Fekrirad, Nina Zamani, et al.
Journal of drug targeting (2022) Vol. 30, Iss. 6, pp. 589-602
Closed Access | Times Cited: 11
Circular RNA circFGFR1 Functions as an Oncogene in Glioblastoma Cells through Sponging to hsa-miR-224-5p
Qian Zhang, Shan Chen, Yingwei Zhen, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 10
Qian Zhang, Shan Chen, Yingwei Zhen, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 10
FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
Jakub Szymczyk, Martyna Sochacka, Patryk Chudy, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Jakub Szymczyk, Martyna Sochacka, Patryk Chudy, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Underlying mechanisms and clinical potential of circRNAs in glioblastoma
Lei Zhang, Yuan Zhang, Huijuan Gao, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 449-462
Open Access | Times Cited: 4
Lei Zhang, Yuan Zhang, Huijuan Gao, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 449-462
Open Access | Times Cited: 4
Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure
John Gehris, Charlie Ervin, Charlotte Hawkins, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115914-115914
Open Access | Times Cited: 3
John Gehris, Charlie Ervin, Charlotte Hawkins, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115914-115914
Open Access | Times Cited: 3
Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas
Aierpati Maimaiti, Yirizhati Aili, Mirzat Turhon, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
Aierpati Maimaiti, Yirizhati Aili, Mirzat Turhon, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
Protein phosphorylation: A potential target in glioma development
Yu Pi, Chang‐Le Fang, Zhang‐Yu Su
Ibrain (2022) Vol. 8, Iss. 2, pp. 176-189
Open Access | Times Cited: 4
Yu Pi, Chang‐Le Fang, Zhang‐Yu Su
Ibrain (2022) Vol. 8, Iss. 2, pp. 176-189
Open Access | Times Cited: 4
A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma
Xuehui Luo, Qi Wang, Hanmin Tang, et al.
Medicina (2022) Vol. 59, Iss. 1, pp. 23-23
Open Access | Times Cited: 3
Xuehui Luo, Qi Wang, Hanmin Tang, et al.
Medicina (2022) Vol. 59, Iss. 1, pp. 23-23
Open Access | Times Cited: 3
Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide
Pouya Goleij, Ghazaleh Pourali, Arash Raisi, et al.
Molecular Neurobiology (2024)
Closed Access
Pouya Goleij, Ghazaleh Pourali, Arash Raisi, et al.
Molecular Neurobiology (2024)
Closed Access
A paediatric dysembryoplastic neuroepithelial tumour (DNET) with deregulated stem cell markers: a case report
Deema Hussein, Alazouf Alhowity, Rinad Algehani, et al.
Translational Pediatrics (2022) Vol. 11, Iss. 6, pp. 1040-1049
Open Access | Times Cited: 2
Deema Hussein, Alazouf Alhowity, Rinad Algehani, et al.
Translational Pediatrics (2022) Vol. 11, Iss. 6, pp. 1040-1049
Open Access | Times Cited: 2
Up-Regulation of miR-26a-5p Promoted Cell Growth and Tumor Metastasis of Intracranial Malignancy Through Phosphatase and Tensin Homolog Deleted on Chromosome Ten/Phosphatidylinositol3-Kinase/Protein Kinase B Signaling Pathway
Mingtao Xu, Li Xu
Journal of Biomaterials and Tissue Engineering (2023) Vol. 13, Iss. 1, pp. 31-42
Closed Access
Mingtao Xu, Li Xu
Journal of Biomaterials and Tissue Engineering (2023) Vol. 13, Iss. 1, pp. 31-42
Closed Access
MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma
Qian Peng, Lijiao Wang, Shuling Wang, et al.
Neurological Research (2022) Vol. 44, Iss. 10, pp. 879-887
Closed Access
Qian Peng, Lijiao Wang, Shuling Wang, et al.
Neurological Research (2022) Vol. 44, Iss. 10, pp. 879-887
Closed Access
